Phase 2 Study of AHB-137 in HBeAg Negative Chronic Hepatitis B (CHB) Participants in Asia Pacific Region

Clinical trial NCT07370207 · RECRUITING

Trial details

NCT number: NCT07370207
Sponsor: AusperBio Therapeutics Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2026-03-06
Primary completion: 2028-12-31
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.